| abstract |
Abstract The present invention provides combinations of (a) an immunoconjugate comprising a first antibody engineered to have reduced effector function and an effector moiety, and (b) a second antibody engineered to have increased effector function, for use in treating a disease in 5 an individual in need thereof. Further provided are pharmaceutical compositions comprising the combinations, and methods of using them. 10888350_1 (GHMatters) P98458.AU |